Bicycle Therapeutics Stock Analysis

Bicycle Stock Analysis Notes

About 92.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.8. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bicycle Therapeutics recorded a loss per share of 2.9. The entity had not issued any dividends in recent years. Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Bicycle Therapeutics plc was incorporated in 2009 and is headquartered in Cambridge, the United Kingdom. Bicycle Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 119 people. For more info on Bicycle Therapeutics please contact Kevin MBA at 44 1223 261 503 or go to https://www.bicycletherapeutics.com.

Bicycle Therapeutics Investment Alerts

Bicycle Therapeutics Upcoming and Recent Events

Bicycle Largest EPS Surprises

View All Earnings Estimates

Bicycle Therapeutics Environmental, Social, and Governance (ESG) Scores

Bicycle Stock Institutional Investors

Note, although Bicycle Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bicycle Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 636.66 M.

Bicycle Profitablity

Management Efficiency

Bicycle Therapeutics has return on total asset (ROA) of (0.169) % which means that it has lost $0.169 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2904) %, meaning that it created substantial loss on money invested by shareholders. Bicycle Therapeutics' management efficiency ratios could be used to measure how well Bicycle Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of March 25, 2025, Return On Tangible Assets is expected to decline to -0.19. In addition to that, Return On Capital Employed is expected to decline to -0.25. At present, Bicycle Therapeutics' Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 10.2 M, whereas Non Current Assets Total are forecasted to decline to about 19.7 M.

Technical Drivers

As of the 25th of March, Bicycle Therapeutics shows the mean deviation of 2.46, and Risk Adjusted Performance of (0.18). Bicycle Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Bicycle Therapeutics Price Movement Analysis

Bicycle Therapeutics Insider Trading Activities

Bicycle Therapeutics Outstanding Bonds

Bicycle Therapeutics Predictive Daily Indicators

Bicycle Therapeutics Corporate Filings

Bicycle Therapeutics Forecast Models

Bicycle Therapeutics' time-series forecasting models are one of many Bicycle Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bicycle Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bicycle Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bicycle shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bicycle Therapeutics. By using and applying Bicycle Stock analysis, traders can create a robust methodology for identifying Bicycle entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bicycle analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bicycle analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Bicycle Therapeutics stock analysis indicators help investors evaluate how Bicycle Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bicycle Therapeutics shares will generate the highest return on investment. By understating and applying Bicycle Therapeutics stock analysis, traders can identify Bicycle Therapeutics position entry and exit signals to maximize returns.

When running Bicycle Therapeutics' price analysis, check to measure Bicycle Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicycle Therapeutics is operating at the current time. Most of Bicycle Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicycle Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicycle Therapeutics' price. Additionally, you may evaluate how the addition of Bicycle Therapeutics to your portfolios can decrease your overall portfolio volatility.